Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 5.5B | 5.8B | 5.4B |
Cost of revenue | 3.1B | 3.0B | 3.0B | 2.8B |
Gross profit | 2.8B | 2.6B | 2.7B | 2.6B |
Operating expense | ||||
Research & development | 5.9M | 7.8M | 6.6M | 7.7M |
Selling general and admin | 2.3B | 2.1B | 2.2B | 2.1B |
Other operating expenses | — | — | — | — |
Operating income | 484.5M | 437.7M | 487.2M | 442.6M |
Non operating interest income | ||||
Income | 17.0M | 26.0M | 19.0M | 26.5M |
Expense | 28.8M | 28.9M | 27.0M | 25.2M |
Other income expense | — | — | — | — |
Pretax income | 464.6M | 338.8M | 469.3M | 446.1M |
Tax provision | 92.3M | 66.1M | 91.5M | 89.8M |
Net income | 372.2M | 272.7M | 377.8M | 356.3M |
Basic EPS | 4.4 | — | 4.4 | 4.2 |
Diluted EPS | 4.3 | — | 4.3 | 4.2 |
Basic average shares | 82.9M | — | 82.4M | 82.5M |
Diluted average shares | 85.7M | — | 84.8M | 84.1M |
EBITDA | 1.1B | 933.5M | 1.1B | 1.0B |
Net income from continuing op. | 464.6M | 338.8M | 469.3M | 446.1M |
Minority interests | -6.6M | -4.0M | -15.0M | -6.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |